Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of beta1-adrenergic receptor polymorphisms in heart failure.

Heart failure clinics - 1 Jan 2010

Liggett Stephen B

Abstract excerpt

The major pathologic beta(1)-adrenergic receptor (beta(1)-AR) subtype in heart failure is beta(1)-AR. The authors' laboratory has thus pursued genetic variation of the beta(1)-AR gene at the molecular, cellular, physiologic, and clinical levels as the potential basis for interindividual variability in the response to beta-blocker treatment during heart failure. This article reviews these findings, with emphasis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenylyl Cyclases
Share to Adrenergic beta-Antagonists
Share to Antihypertensive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Failure

Share to Myocardium

Share to Polymorphism, Genetic

Share to Receptors, Adrenergic, beta-1

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 19945058
DOI: 10.1016/j.hfc.2009.08.011
PMCID: PMC2825120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of beta1-adrenergic receptor polymorphisms in heart failure.PMID 19945058Read ↗

Pharmacogenetics of heart failure.Semantic proximity Read ↗

Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.Semantic proximity Read ↗

Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.Semantic proximity Read ↗

Genetics and pharmacogenetics in heart failure.Semantic proximity Read ↗

Beta-adrenoceptor polymorphisms and heart failure.Semantic proximity Read ↗

[Adrenergic receptor polymorphisms in heart failure: what can genetics explain?].Semantic proximity Read ↗

Pharmacogenomics of β-adrenergic receptor physiology and response to β-blockade.Semantic proximity Read ↗

Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failureSemantic proximity Read ↗

State of play of pharmacogenetics and personalized medicine in heart failure.Semantic proximity Read ↗

Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions.Semantic proximity Read ↗

Pharmacogenomics of heart failure.Semantic proximity Read ↗

The future of pharmacogenetics in the treatment of heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.